Corbus Pharmaceuticals Holdings, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2013 to Q3 2024.
  • Corbus Pharmaceuticals Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$13.8M, a 37.1% decline year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$38.7M, a 18.5% increase year-over-year.
  • Corbus Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$44.6M, a 5.33% decline from 2022.
  • Corbus Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$42.3M, a 7.22% increase from 2021.
  • Corbus Pharmaceuticals Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$45.6M, a 59% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$38.7M -$13.8M -$3.73M -37.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$35M -$10M -$1.21M -13.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$33.8M -$6.9M +$10.8M +61.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$44.6M -$8.02M +$2.86M +26.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$47.5M -$10.1M -$1.27M -14.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$46.2M -$8.78M +$4.46M +33.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$50.7M -$17.7M -$8.31M -88% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$42.3M -$10.9M -$618K -6.03% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$41.7M -$8.78M -$6.61M -304% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$35.1M -$13.2M +$3.89M +22.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$39M -$9.44M +$6.63M +41.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$45.6M -$10.3M -$1.65M -19.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$44M -$2.18M +$32.7M +93.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$76.7M -$17.1M +$21M +55% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$97.7M -$16.1M +$13.6M +45.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$111M -$8.61M +$18M +67.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$129M -$34.9M -$14.1M -67.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$115M -$38.1M -$40.3M -1870% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$74.9M -$29.7M -$3.42M -13% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$71.5M -$26.6M -$9.27M -53.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 -$62.2M -$20.8M -$6.19M -42.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$56M $2.15M +$14.2M Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 -$70.2M -$26.2M -$14.5M -124% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$55.7M -$17.3M -$6.61M -61.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$49.1M -$14.6M -$7.64M -110% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$41.4M -$12.1M -$4.77M -65.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$36.7M -$11.7M -$4.23M -56.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$32.4M -$10.7M -$3.12M -41.3% Oct 1, 2017 Dec 31, 2017 10-K 2018-03-12
Q3 2017 -$29.3M -$6.97M -$1.62M -30.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$27.7M -$7.3M -$3.11M -74.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$24.6M -$7.47M -$4.57M -158% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$20M -$7.57M -$5.07M -203% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$14.9M -$5.35M -$3.09M -137% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$11.8M -$4.19M -$1.63M -63.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$10.2M -$2.89M -$1.36M -88.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$8.85M -$2.5M -$1.24M -98.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-12
Q3 2015 -$7.61M -$2.25M -$1.59M -242% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$6.02M -$2.56M -$2.06M -408% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-12
Q1 2015 -$3.96M -$1.54M -$1.42M -1224% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$2.54M -$1.26M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-28
Q3 2014 -$660K -$600K -1008% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$505K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$116K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 -$59.6K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.